April 1, 2025: MaaT Pharma advancing next frontier biotherapeutics with microbiome-driven therapies - BioTuesdays - MaaT Pharma

To read the article, click here!

Previous PostApril 4, 2025: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
Next PostMarch 31, 2025: MaaT Pharma To Present New Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club